SYTL1 and fetal growth restriction: As for Ucp1 and Sytl1, they do not seem to have alternative promoters, yet the promoter methylation levels also were changed in the IUGR neonates, albeit in the opposite direction of genistein treatment (higher methylation in IUGR than in control samples) [24].